Menu
GeneBe

OCA2

OCA2 melanosomal transmembrane protein

Basic information

Region (hg38): 15:27754874-28099315

Previous symbols: [ "D15S12", "P", "EYCL3", "EYCL2" ]

Links

ENSG00000104044NCBI:4948OMIM:611409HGNC:8101Uniprot:Q04671AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • oculocutaneous albinism type 2 (Definitive), mode of inheritance: AR
  • oculocutaneous albinism type 2 (Supportive), mode of inheritance: AR
  • oculocutaneous albinism type 2 (Definitive), mode of inheritance: AR
  • oculocutaneous albinism type 2 (Strong), mode of inheritance: AR
  • oculocutaneous albinism type 2 (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Albinism, oculocutaneous, type II; Albinism, brown oculocutaneous; Skin/hair/eye pigmentation 1AD/ARGeneralIn Albinism, oculocutaneous, type II; Albinism, brown oculocutaneous, Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing; Skin/hair/eye pigmentation 1 is a susceptibility factor locus for a multifactorial disease (melanoma)Dermatologic; Ophthalmologic14904868; 687204; 7920637; 8302318; 7874125; 7762554; 7887411; 8723691; 10649493; 11179026; 12163334; 14704187; 15889046; 16341609; 17236130; 17952075; 18449927; 18680187; 20861488; 21471978; 21085994; 23103111

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the OCA2 gene.

  • not provided (852 variants)
  • Tyrosinase-positive oculocutaneous albinism (196 variants)
  • SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES (81 variants)
  • not specified (64 variants)
  • OCA2-related condition (29 variants)
  • Inborn genetic diseases (28 variants)
  • Tyrosinase-positive oculocutaneous albinism;SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES (22 variants)
  • Oculocutaneous albinism (13 variants)
  • Nonsyndromic Oculocutaneous Albinism (9 variants)
  • Albinism (3 variants)
  • SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES;Tyrosinase-positive oculocutaneous albinism (3 variants)
  • - (2 variants)
  • See cases (1 variants)
  • 6 conditions (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the OCA2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
7
clinvar
160
clinvar
14
clinvar
182
missense
13
clinvar
42
clinvar
245
clinvar
22
clinvar
7
clinvar
329
nonsense
15
clinvar
6
clinvar
1
clinvar
22
start loss
0
frameshift
36
clinvar
20
clinvar
2
clinvar
58
inframe indel
1
clinvar
5
clinvar
6
splice donor/acceptor (+/-2bp)
19
clinvar
21
clinvar
1
clinvar
41
splice region
3
30
20
2
55
non coding
1
clinvar
3
clinvar
15
clinvar
93
clinvar
66
clinvar
178
Total 84 94 276 275 87

Highest pathogenic variant AF is 0.000131

Variants in OCA2

This is a list of pathogenic ClinVar variants found in the OCA2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
15-27754978-G-T Tyrosinase-positive oculocutaneous albinism Uncertain significance (Jan 12, 2018)888264
15-27755017-C-G Tyrosinase-positive oculocutaneous albinism Uncertain significance (Apr 27, 2017)888265
15-27755021-G-C Tyrosinase-positive oculocutaneous albinism Uncertain significance (Jan 12, 2018)888266
15-27755088-A-G Tyrosinase-positive oculocutaneous albinism Uncertain significance (Jan 12, 2018)315455
15-27755117-C-T Tyrosinase-positive oculocutaneous albinism Likely benign (Apr 27, 2017)888267
15-27755222-G-A Tyrosinase-positive oculocutaneous albinism Uncertain significance (Jan 13, 2018)315456
15-27755334-T-C Tyrosinase-positive oculocutaneous albinism • Tyrosinase-positive oculocutaneous albinism;SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES Uncertain significance (Oct 15, 2021)888268
15-27755338-T-C Tyrosinase-positive oculocutaneous albinism Benign (Jan 13, 2018)315457
15-27755367-C-T Tyrosinase-positive oculocutaneous albinism Uncertain significance (Jan 12, 2018)315458
15-27755387-A-G Tyrosinase-positive oculocutaneous albinism Uncertain significance (Nov 07, 2021)499953
15-27755391-A-G Likely benign (Nov 10, 2023)1663840
15-27755398-CCCA-C Uncertain significance (Feb 23, 2022)1437021
15-27755399-C-T Uncertain significance (Mar 12, 2022)1416941
15-27755401-AC-A Uncertain significance (Feb 22, 2022)2137621
15-27755403-C-A Likely benign (Jan 17, 2024)1545246
15-27755403-C-T Likely benign (May 11, 2023)2832426
15-27755404-A-T Uncertain significance (Jun 20, 2022)1477436
15-27755405-C-T Benign (Jan 31, 2024)787422
15-27755408-C-T Benign (Jan 27, 2024)1622620
15-27755411-G-A Uncertain significance (Aug 10, 2022)1463223
15-27755414-C-G Pathogenic (Oct 30, 2023)2736158
15-27755424-A-C Pathogenic (Sep 21, 2023)2152218
15-27755426-AAC-A Pathogenic (Oct 29, 2023)2772698
15-27755430-C-T Uncertain significance (Oct 13, 2022)2117118
15-27755432-T-A Conflicting classifications of pathogenicity (Nov 15, 2023)1305143

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
OCA2protein_codingprotein_codingENST00000354638 23344484
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.91e-130.96812564101071257480.000426
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.8335354831.110.00003195393
Missense in Polyphen204172.731.1812047
Synonymous-1.422322061.130.00001541750
Loss of Function2.322743.50.6210.00000210501

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.004920.00368
Ashkenazi Jewish0.000.00
East Asian0.0004370.000435
Finnish0.000.00
European (Non-Finnish)0.0002660.000264
Middle Eastern0.0004370.000435
South Asian0.00003270.0000327
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Could be involved in the transport of tyrosine, the precursor to melanin synthesis, within the melanocyte. Regulates the pH of melanosome and the melanosome maturation. One of the components of the mammalian pigmentary system. Seems to regulate the post-translational processing of tyrosinase, which catalyzes the limiting reaction in melanin synthesis. May serve as a key control point at which ethnic skin color variation is determined. Major determinant of brown and/or blue eye color. {ECO:0000269|PubMed:11310796, ECO:0000269|PubMed:15262401, ECO:0000269|PubMed:18252222, ECO:0000269|PubMed:22234890, ECO:0000269|PubMed:7601462}.;
Disease
DISEASE: Albinism, oculocutaneous, 2 (OCA2) [MIM:203200]: An autosomal recessive disorder in which the biosynthesis of melanin pigment is reduced in skin, hair, and eyes. Although affected infants may appear at birth to have complete absence of melanin pigment, most patients acquire small amounts of pigment with age. Visual anomalies include decreased acuity and nystagmus. The phenotype is highly variable. The hair of affected individuals may turn darker with age, and pigmented nevi or freckles may be seen. African and African American individuals may have yellow hair and blue-gray or hazel irides. One phenotypic variant, 'brown OCA,' has been described in African and African American populations and is characterized by light brown hair and skin color and gray to tan irides. {ECO:0000269|PubMed:10649493, ECO:0000269|PubMed:10671067, ECO:0000269|PubMed:10987646, ECO:0000269|PubMed:12713581, ECO:0000269|PubMed:12727022, ECO:0000269|PubMed:12876664, ECO:0000269|PubMed:17385796, ECO:0000269|PubMed:23504663, ECO:0000269|PubMed:7762554, ECO:0000269|PubMed:7874125, ECO:0000269|PubMed:9259203}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Prader-Willi and Angelman Syndrome;Metabolism of amino acids and derivatives;Tyrosine metabolism;Biopterin metabolism;Metabolism;Melanin biosynthesis (Consensus)

Recessive Scores

pRec
0.366

Intolerance Scores

loftool
0.0878
rvis_EVS
0.13
rvis_percentile_EVS
62.75

Haploinsufficiency Scores

pHI
0.123
hipred
N
hipred_score
0.300
ghis
0.449

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.208

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Oca2
Phenotype
liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); pigmentation phenotype; hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; vision/eye phenotype; digestive/alimentary phenotype; hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; homeostasis/metabolism phenotype; immune system phenotype; cellular phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype;

Zebrafish Information Network

Gene name
oca2
Affected structure
melanocyte
Phenotype tag
abnormal
Phenotype quality
decreased amount

Gene ontology

Biological process
eye pigment biosynthetic process;spermatid development;cell population proliferation;tyrosine transport;melanocyte differentiation;melanin biosynthetic process;transmembrane transport
Cellular component
cytoplasm;lysosomal membrane;endoplasmic reticulum membrane;endosome membrane;integral component of membrane;melanosome membrane
Molecular function
transporter activity;L-tyrosine transmembrane transporter activity;protein binding